"Pfizer and its German partner, BioNTech, have begun testing a vaccine tailored to battle the omicron variant of the coronavirus, the companies announced Tuesday."
"Pfizer and its German partner, BioNTech, have begun testing a vaccine tailored to battle the omicron variant of the coronavirus, the companies announced Tuesday."